Search

Your search keyword '"Gene Products, gag pharmacology"' showing total 13 results

Search Constraints

Start Over You searched for: Descriptor "Gene Products, gag pharmacology" Remove constraint Descriptor: "Gene Products, gag pharmacology" Topic viral proteins Remove constraint Topic: viral proteins
13 results on '"Gene Products, gag pharmacology"'

Search Results

1. HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines.

2. HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.

3. Reconstitution of cleavage of human immunodeficiency virus type-1 (HIV-1) RNAs.

4. Conformational change of dimerization initiation site of HIV-1 genomic RNA by NCp7 or heat treatment.

5. HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor.

6. HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase.

7. A recombinant HIV gag p17 protein suppresses the function of normal T cells.

8. HIV-1 nucleocapsid protein and replication protein A influence the strand displacement DNA synthesis of lentiviral reverse transcriptase.

9. NCp7 activates HIV-1Lai RNA dimerization by converting a transient loop-loop complex into a stable dimer.

10. Analysis of the nucleic acid annealing activities of nucleocapsid protein from HIV-1.

11. HIV Gag p17 protein impairs proliferation of normal lymphocytes in vitro.

12. Independent and synergistic effects of disulfide bond formation, beta 2-microglobulin, and peptides on class I MHC folding and assembly in an in vitro translation system.

13. Conjugates of synthetic lymphocyte-activating lipopeptides with segments from HIV proteins induce protein-specific antibody formation.

Catalog

Books, media, physical & digital resources